Despite their potential, DMTs also face several challenges:
Resistance: Cancer cells can develop resistance to targeted therapies, making them less effective over time. Cost: Many DMTs are expensive, posing financial challenges for patients and healthcare systems. Access: Availability of these advanced therapies can be limited, especially in low-resource settings. Side Effects: While generally less severe than conventional treatments, DMTs can still cause significant side effects, such as immune-related adverse events.
